National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 61507 [2010-24932]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 192 / Tuesday, October 5, 2010 / Notices
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: September 30, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2010–24984 Filed 10–4–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0001]
General and Plastic Surgery Devices
Panel of the Medical Devices Advisory
Committee; Amendment of Notice
AGENCY:
Food and Drug Administration,
HHS.
mstockstill on DSKH9S0YB1PROD with NOTICES
ACTION:
BILLING CODE 4160–01–S
The Food and Drug Administration
(FDA) is announcing an amendment to
the notice of meeting of the General and
Plastic Surgery Devices Panel of the
Medical Devices Advisory Committee.
This meeting was announced in the
Federal Register of August 16, 2010 (75
FR 49940). The amendment is being
made to reflect a change in the Agenda
portion of the document. There are no
other changes.
FOR FURTHER INFORMATION CONTACT:
Margaret McCabe-Janicki, Center for
Devices and Radiological Health, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 66, rm. 1535,
Silver Spring, MD 20993–0002, 301–
796–7029, or FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area), code 3014512519. Please call the
Information Line for up-to-date
information on this meeting.
SUPPLEMENTARY INFORMATION: In the
Federal Register of August 16, 2010,
FDA announced that a meeting of the
General and Plastic Surgery Devices
Panel of the Medical Devices Advisory
Committee would be held on November
18, 2010. On page 49940, in the second
column, in the Agenda portion of the
document, the first full paragraph is
changed to read as follows:
Agenda: On November 18, 2010, the
committee will discuss, make
recommendations, and vote on
information related to the premarket
approval application for MelaFind,
sponsored by MELA Sciences.
MelaFind(R) is a non-invasive and
objective multi-spectral computer vision
system designed to aid physicians in the
detection of early melanoma from
18:36 Oct 04, 2010
Dated: September 30, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2010–24983 Filed 10–4–10; 8:45 am]
Notice.
VerDate Mar<15>2010
among clinically atypical (those having
one or more clinical or historical
characteristics of melanoma, such as
asymmetry, border irregularity, color
variegation, diameter greater than 6
millimeters, evolving, patient concern,
regression, and ‘‘ugly duckling’’)
cutaneous pigmented lesions that are
non-ulcerated, not bleeding, and less
than 2.2 centimeters in diameter, when
a physician chooses to obtain additional
information before making a final
decision to biopsy to rule out
melanoma.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to the advisory committees.
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Research Centers at Minority-Serving
Institutions.
Date: October 20, 2010.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Chang Sook Kim, PhD,
Scientific Review Officer, Review Branch,
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7190,
Bethesda, MD 20892, 301–435–0287,
carolko@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
61507
Mentored Patient Oriented Research Career
Development Awards.
Date: October 21, 2010.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 8120 Military Road, NW.,
Washington, DC 20015.
Contact Person: Stephanie J. Webb, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7196,
Bethesda, MD 20892, 301–435–0291,
stephanie.webb@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Programs of Excellence in Glycosciences.
Date: October 25–26, 2010.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: YingYing Li-Smerin, MD,
PhD, Scientific Review Officer, Office of
Scientific Review, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6701 Rockledge Drive, Room 7184, Bethesda,
MD 20892–7924, 301–435–0277,
lismerin@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Program Project in Cardiac Fibrillation.
Date: October 28, 2010.
Time: 10 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: William J Johnson, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7178,
Bethesda, MD 20892–7924, 301–435–0725,
johnsonwj@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 28, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–24932 Filed 10–4–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
E:\FR\FM\05OCN1.SGM
05OCN1
]]>Agencies
[Federal Register Volume 75, Number 192 (Tuesday, October 5, 2010)]
[Notices]
[Page 61507]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-24932]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Research Centers at Minority-Serving
Institutions.
Date: October 20, 2010.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Chang Sook Kim, PhD, Scientific Review Officer,
Review Branch, DERA, National Heart, Lung, and Blood Institute, 6701
Rockledge Drive, Room 7190, Bethesda, MD 20892, 301-435-0287,
carolko@mail.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Mentored Patient Oriented Research Career
Development Awards.
Date: October 21, 2010.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 8120 Military
Road, NW., Washington, DC 20015.
Contact Person: Stephanie J. Webb, PhD, Scientific Review
Officer, Review Branch/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7196, Bethesda, MD 20892, 301-
435-0291, stephanie.webb@nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Programs of Excellence in Glycosciences.
Date: October 25-26, 2010.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: YingYing Li-Smerin, MD, PhD, Scientific Review
Officer, Office of Scientific Review, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6701 Rockledge
Drive, Room 7184, Bethesda, MD 20892-7924, 301-435-0277,
lismerin@nhlbi.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Program Project in Cardiac Fibrillation.
Date: October 28, 2010.
Time: 10 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: William J Johnson, PhD, Scientific Review
Officer, Review Branch/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892-7924,
301-435-0725, johnsonwj@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 28, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-24932 Filed 10-4-10; 8:45 am]
BILLING CODE 4140-01-P
